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Abstract: Background: Phthalates are chemicals which are widespread in the environment.
Although the impacts on health of such exposure are unclear, there is evidence of a possible impact
on the incidence of a diverse range of diseases. Monitoring of human exposure to phthalates is
therefore important. This study aimed to determine the extent of phthalate exposure among mothers
and their children in both rural and urban areas in Ireland, and to identify factors associated with
elevated concentrations. It formed part of the ‘Demonstration of a study to Co-ordinate and Perform
Human Biomonitoring on a European Scale’ (DEMOCOPHES) pilot biomonitoring study. Methods:
the concentration of phthalate metabolites were determined from a convenience sample of 120
mother/child pairs. The median age of the children was 8 years. A questionnaire was used to collect
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information regarding lifestyle and environmental conditions of the children and mothers. Rigorous
quality assurance within DEMOCOPHES guaranteed the accuracy and international comparability
of results. Results: Phthalate metabolites were detected in all of the samples from both children
and mothers. Concentrations were significantly higher in respondents from families with lower
educational attainment and in those exposed to such items as polyvinyl chloride (PVC), fast food
and personal care products (PCP). Conclusions: The study demonstrates that human biomonitoring
for assessing exposure to phthalates can be undertaken in Ireland and that the exposure of the
population is widespread. Further work will be necessary before the consequences of this exposure
are understood.
Keywords: phthalates; human biomonitoring; exposure; endocrine disruptors
1. Introduction
Phthalates are a group of chemicals found in many consumer goods, including personal
care products (PCPs), cosmetics, plastic products, children’s toys, household furnishings and
consumption of convenience and fast foods such as ready prepared meals and takeaways. Phthalates
provide flexibility to rigid materials such as polyvinyl chloride (PVC) and they can also act as a
lubricant [1]. In addition, phthalates may be present in food as a result of migration from food
packaging [2,3].They are not chemically bound to the products to which they are added and can
be released to the environment during use or disposal. The widespread use of phthalates in daily
life results in exposure from direct contact with products containing phthalates, from consuming
food which has been in contact with phthalate containing packaging material and by inhalation of
contaminated air. Phthalate diesters are rapidly metabolized, initially by substituting one of the
side-chains with glucuronate. Longer hydrocarbon side-chains may be oxidized to increase solubility.
These are quickly excreted and do not accumulate in the body.
The impact of phthalate exposure to human health is unclear [4]. There is concern that
some phthalates may act as endocrine disrupting compounds, leading to adverse reproductive and
developmental effects [5]. Studies have shown significant impacts on laboratory animals but due to
inadequate data, the human health impacts from low dose exposure are difficult to determine [6].
Nevertheless, some studies have shown that phthalate exposure adversely affects human male
reproductive development [7] and sperm quality [8,9], and is also associated with risk factors for
cancer, asthma and allergies [10]. Phthalates have been associated with obesity [11] but their impact on
overall cardiovascular health is unclear [12]. As a result, there is increasing public health concern of
the general population’s exposure to phthalates [4].
Due to their widespread use and the lack of clarity in terms of effects, it is important that
exposure concentrations are monitored. There is a relative absence of data on exposure to phthalates
in Ireland. Human biomonitoring (HBM) is a tool by which concentrations of exposure of humans
to environmental contaminants may be assessed. This study formed part of the DEMOCOPHES
pilot study across 17 European Union countries [1,13] and which involved monitoring of four key
environmental pollutants (mercury, cadmium, cotinine and phthalates), in 1844 mother/child pairs.
The aim of the present study was to determine the concentrations of seven biomarkers, metabolites
from five phthalates, in urine samples from mothers and their children in Ireland. The metabolites are
arranged in order of ascending molecular weight (Table 1).
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Table 1. Metabolites and the parent compounds assessed.
Metabolite Parent Compound
Monoethyl phthalate (MEP) Diethyl phthalate (DEP)
Monobutyl phthalate (MnBP) Dibutyl phthalate (DBP)
Monoisobutyl phthalate (MiBP) Diisobutyl phthalate (DiBP)
Monobenzyl phthalate (MBzP) Benzylbutyl phthalate (BBP)
Mono-2-ethylhexyl phthalate (MEHP)
Di-2-ethyhexyl phthalate (DEHP)Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP)
Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP)
2. Materials and Methods
2.1. Sampling
A convenience sample of eight schools (four urban and four rural) participated in the study.
Schools in urban and rural locations were contacted by letter by Environmental Health Officers (EHOs),
describing the project and inviting their participation in the study. Urban and rural locations were
determined by population density data from the Central Statistics Office, in Dublin. Larger schools
were chosen in order to maximize the response rate. Following receipt of consent from the school,
parent information packs and an invitation letter were given to all children aged 6 to 11 years attending
the school. The criteria for inclusion were that participants should not be in hospitals, institutions or
homeless, and be in good health without any metabolic or renal condition. In addition, mothers had to
be aged 45 years or less, to have lived in the area for at least five years, and to be able to speak English
well. Of the invitation letters (1185 urban and 650 rural), replies were received from 551 families (30%
response rate; 20% urban and 50% rural). Of these, 311 were positive (142 urban and 169 rural; 12%
and 26% of invitation letters, respectively). A further 33 families were excluded during quota sampling
as they did not meet the eligibility criteria. Following quota sampling, 120 mother / child pairs, (60
urban and 60 rural) were subsequently included in the study (6.5% of the families contacted). 120
mother/child pairs was the standardised number of respondents for all countries participating in the
DEMOCOPHES study).
Appointments were made with the mothers who had agreed to participate, for a home visit to take
place at a time that suited the mother and child. Following a home visit from the Environmental Health
Officer (EHO) to obtain consent, the EHO subsequently visited the selected families in their homes
from October 2011 to January 2012 to administer a questionnaire. The questionnaire was performed by
the EHO as an interviewer guided questionnaire with the mother. The aim of the questionnaire was to
obtain socio-demographic details and information on both diet and possible exposure to phthalate
containing products. Sociodemographic profile variables included highest education concentration in
family (primary or lower secondary, higher secondary, third concentration), marital status (single),
age of mother (<35, 35–40, >40) and child (5–8, 9–11), gender of child, smoking characteristics of
household (mothers who smoke, households with at least one smoker), employment outside home
(mothers and fathers). Information in terms of dietary and other possible sources of phthalate exposure
included consumption (several times a week or once a week or less) of meat, convenience or fast
food and chewing gum; time spent in a new car (at least one hour a day, or one hour a day or less),
wearing plastic gloves (daily, less than daily, never), using personal care products (high, moderate,
low), PVC in house (in floors and walls, in floors or walls, no PVC), and area of residence (urban or
rural). The questionnaire took approximately forty five minutes to complete and the mean duration
of the home visit was two hours and fifteen minutes. Early morning urine samples were taken from
mother and child at this time. The urine samples were collected from the home in calibrated cool-boxes
and transported to the survey office where they were stored in a designated fridge at temperatures
between 4–8◦C. Samples were stored for a maximum of five days and were transported in cool-boxes
to the laboratory at the end of each week. A gift voucher was given to the mother as a gratuity. Quality
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audits were carried out in each survey office by another fieldworker to ensure consistency and that a
standardized approach was adopted during the fieldwork.
2.2. Chemical Analysis
Urine samples were analysed by the Public Analyst Laboratory (Health Service Executive, Dublin,
Ireland), employing a validated procedure. Quality standards were assured by successfully completing
three proficiency tests (a requirement of the DEMOCOPHES project) [1] The limits of detection
(LOD) were between 0.015 to 0.33 µg/L, and the limits of quantification (LOQ) were between 0.05
to 1 µg/L. Isotopically labelled internal standards were added to an aliquot of urine which was
subjected to enzymatic hydrolysis at 40◦C for two hours. Sample clean-up and analyte enrichment was
carried out on-line using a Restricted Access Material and back flushed onto an analytical column for
chromatographic separation. Detection was by tandem mass spectrometry with positive electrospray
ionisation. To allow for differences in urinary concentrations, the results are presented per gram
of creatinine.
2.3. Statistical Analysis
As data for phthalate metabolites were not normally distributed, Mann Whitney U tests were
undertaken to determine the significance of differences between biomarker concentrations in mothers
and children. One-way Anova (on log transformed data) was undertaken to establish the significance
of differences by sociodemographic factors and other factors associated with exposure. Data analysis
was undertaken using SPSS Statistics v.23 (IBM Inc., Armonk, NY, USA). Ethical approval was obtained
from the Faculty of Public Health Medicine (Royal College of Physicians of Ireland, 23 September 2011).
3. Results
3.1. Profile
The socio-demographic profile of the respondents is outlined (Table 2). The average age of
mothers was 38.1 years (median = 39.0) and 53% (n = 63) had received third-concentration education.
There was a smoker in 43% of households, with 29% (n = 35) of mothers smoking.
Table 2. Sociodemographic profile of respondents.
Profile No. %
Area of residence
Urban 60 50.0
Rural 60 50.0
Highest educational concentration in family 8 6.7
Primary or lower secondary 49 40.8
Higher secondary or post-secondary, non-third concentration
Third-concentration education 63 52.5
Marital status
Single mothers 16 13.3
Age of mothers
<35 years 34 28.3
35–40 years 41 34.2
>40 years 45 37.5
Age of child (years)
5–8 61 50.8
9–11 59 49.2
Gender of child
Boy 63 52.5
Girl 57 47.5
Smoking characteristics
Mothers who smoke 35 29.2
Households with at least one smoker 51 42.5
Working outside the home
Mothers 71 59.2
Fathers 82 78.8
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Most of the fathers (79%) and over a half of the mothers (59%) worked outside the home.
The average age of children was 8.5 years (median = 8.0) with a larger proportion of boys (53%,
n = 63).
3.2. Overall Phthalate Exposure
All seven phthalate metabolites were detected in all of the Irish children’s samples and in addition,
five of the seven metabolites were detected in all of the Irish mothers’ samples with the remaining two,
MEHP and MBzP detected in 90% and 97.5% of samples respectively (Table 3).
The two phthalates with the highest measured geometric mean concentration in children were
MiBP, followed by MEP; while in mothers, the opposite occurred, with highest concentration being
MEP, followed by MiBP. For MEP, geometric mean concentrations were higher in mothers than children.
This association was statistically significant (p < 0.05). The geometric mean of urinary concentrations
of six of the seven phthalate metabolites was higher in Irish children than in their mothers. With the
exception of MEHP, these higher concentrations were statistically significant (p < 0.05).
Table 3. Exposure of mothers and children to phthalates µg/g (creatinine adjusted).
Phthalate Mothers Children Mann Whitney Utest
MEP 6006.5 (mean rank
mother = 130.5,
child = 110.6)
p = 0.026
Percent above LoQ 100.0 100.0
Geometric mean 50.2 38.7
Arithmetic mean 88.0 53.6
Minimum/Maximum 6.0/725.0 4.4/462.1
MnBP 5773.5 (mean rank
mother = 108.6,
child = 132.4)
p = 0.008
Percent above LoQ 100.0 100.0
Geometric mean 18.5 26.1
Arithmetic mean 22.8 29.8
Minimum/Maximum 3.32/159.3 10.1/511.4
MiBP 4722.5 (mean rank
mother = 99.9,
child = 141.2)
p < 0.001
Percent above LoQ 100.0 100.0
Geometric mean 23.8 41.4
Arithmetic mean 31.0 55.7
Minimum/Maximum 5.1/181.2 7.4/91.5
MBzP 5235.5 (mean rank
mother = 104.1,
child = 136.9)
p < 0.001
Percent above LoQ 97.5 100.0
Geometric mean 3.1 5.4
Arithmetic mean 5.1 8.2
Minimum/Maximum 0.4/50.4 1.0/65.9
MEHP 6831.5 (mean rank
mother = 117.4,
child = 123.6)
p = 0.493
Percent above LoQ 90.0 100.0
Geometric mean 2.8 3.5
Arithmetic mean 4.1 4.5
Minimum/Maximum 0.5/28.8 1.15/20.5
MEHHP 4281.0 (mean rank
mother = 96.2,
child = 14.8)
p < 0.001
Percent above LoQ 100.0 100.0
Geometric mean 17.0 32.8
Arithmetic mean 23.1 39.8
Minimum/Maximum 4.2/336.5 12.4/284.8
MEOHP 4139.5 (mean rank
mother = 95.0,
child = 146.0)
p < 0.001
Percent above LoQ 100.0 100.0
Geometric mean 8.8 17.7
Arithmetic mean 11.7 21.6
Minimum/Maximum 2.0/125.1 6.3/157.1
3.3. Sociodemographic Patterns
Age was a factor in determining exposure in children to MBzP and MnBP, with higher
concentrations of these compounds found in children aged 5–8 years, when compared to children
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aged 9–11 years (p = 0.04 and 0.03) respectively. Higher concentrations of MEOHP were also found in
children living in urban areas when compared to rural areas (p = 0.03). The only sociodemographic
variable associated with exposure in both mothers and children was education, where higher
concentrations of MiBP were inversely related to educational attainment. Higher concentrations
were found in mothers who had just completed education to primary concentration in contrast to
mothers who had completed third-concentration education (p = 0.006), this association was also noted
in their children (p = 0.002). There were no other significant sociodemographic variables associated
with exposure concentrations (Table 4).
Table 4. Association between phthalate exposure and sociodemographic variables *.
Compound Irish Children Irish Mothers
MnBP Younger > olderp = 0.03 p > 0.05
MiBP Decreased educational attainment in the familyp = 0.002
Decreased educational attainment in the family
p = 0.006
MBzP Younger > olderp = 0.04 p > 0.05
MEOHP Urban > ruralp = 0.03 p > 0.05
* Results where significant association found in mother or child (p < 0.05).
3.4. Other Factors Associated with Exposure
All statistically significant associations between phthalate concentrations and environmental
exposures in the Irish children and their mothers are shown (Table 5). MiBP, the compound with the
highest geometric mean in children at 41.4 µg/g creatinine, was significantly associated with exposure
to PVC in the house, (p = 0.007). Concentrations of MEP, the compound with the highest recorded
value in mothers at 50.2 µg/g creatinine and second highest in children, was associated with the use of
personal care products by Irish children (p = 0.02) and with the consumption of convenience foods in
the last 24 h by mothers (p = 0.02). There was also an inverse association between the consumption of
meat and concentrations of MEP in mothers (p = 0.02).
Table 5. Association between phthalate exposure and environmental variables.
Compound Irish Children Irish Mothers
MEP PCP p = 0.02 ↑↑ Consumption of meat p = 0.02 ↓↑Convenience foods in last 24 h p = 0.02 ↑↑
MnBP p > 0.05 Plastic gloves p = 0.03 ↑↑
MiBP PVC p = 0.007 ↑↑ Consumption of fast food p = 0.02 ↑↑
MBzP Cheese p = 0.007 ↓↑ None
MEHP Chewing gum p = 0.03 ↑↑ p = 0.26
MEHHP Chewing gum p = 0.02 ↑↑ p = 0.52
MEOHP Chewing gum p = 0.005 ↑↑ p = 0.44
Results where significant association found in mother or child (p < 0.05); Key to symbols: ↓↑ = inverse association
↑↑ = positive association.
Concentrations of MEOHP, MEHHP and MEHP (all metabolites of DEHP) in Irish children were
significantly associated with the use of chewing gum. In Irish mothers, concentrations of MiBP were
significantly higher in those who consumed fast food more than once a week (p = 0.02). In addition,
significantly higher concentrations of MnBP were found in mothers who wore plastic gloves (p = 0.03).
An inverse association was noted in children between the concentrations of MBzP and the consumption
of cheese (p = 0.007).
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4. Discussion
This is the first study to examine the exposure of the Irish population to phthalates. It is clear
that exposure to phthalates is widespread, with detectable concentrations of all seven compounds
found in samples from all the children. Five of the seven compounds were detected in all the mothers,
with MBzP in 97.5% and MEP in 90%. The concentrations detected in Irish mothers and children are
comparable, but slightly higher for some compounds than the concentrations found in the overall
DEMOCOPHES cohort [13]. A similarly high pattern of exposure was found in Spain [14] where
phthalates were detected in all the mother and child participants, and in Germany, where all of the
phthalate compounds were detected in all of the participants apart from MEHP which was detected
in 93% of children and 85% of mothers [15]. Similarly, a population based survey in Sweden found
that all of the children and mothers had detectable concentrations of phthalate compounds with the
exception of MEHP, which was found in 98% of mothers [16]. Such high exposure patterns are not
surprising as phthalates have been described as being “ubiquitous” in the environment [5].
The geometric mean concentrations of the Irish children were substantially higher than those
found in their mothers, with the exception of MEP. Similarly, the geometric mean concentrations of
the DEMOCOPHES children were much higher than their mothers, with the exception again being
MEP [13]. A similar pattern was also noted in Spain [14] in Sweden [16] and in the USA where,
apart from MEP, all of the compounds were detected at lower concentrations in mothers than in
their children [17]. MEP is a common constituent of cosmetic and personal care products and it is
not surprising that higher concentrations of MEP metabolites should be found in mothers. Younger
children in Ireland (aged 5–8 years) were at higher risk than older children (aged 9–11 years) for all
compounds, apart from MEP (and MEHP which was the same concentration in both age groups).
Higher concentrations of phthalate compounds were also found in younger children in Germany
when compared to older children [18], and in the UK [19]. A similar pattern was also noted in the
DEMOCOPHES cohort, where younger children again had higher concentrations of all compounds
apart from MEP [13]. The phthalates with the two highest geometric mean concentrations were MiBP
followed by MEP. This is in contrast to adults where the highest concentration was MEP, followed
by MiBP. There is a lack of a consistent pattern for concentrations of MiBP and MEP in other studies.
Studies of children in the UK [19], Germany [15], Austria [20], and the overall DEMOCOPHES cohort
found higher concentrations for MiBP in children than MEP [13]. In contrast, other studies from
Austria [21] and the USA [17] found higher concentrations of MEP. Such variations may be indicative
of the varying exposure of populations to phthalate compounds in general and reflects both the timing
of the study and also country specific differences such as life style and product use [22].
Higher concentrations of phthalates in children in general have been attributed to their relative
body size, their higher hand to mouth behaviour, more time spent on the floor, contact with toys
and by differences in metabolism [23]. These results suggest that there may be a need for stricter
regulation for products specifically designed for children, such as controls on phthalates classified
as endocrine disruptors. In this regard, the recent proposal by the EU to place restrictions on the
phthalate compounds DEHP, DBP, DiBP and BBP is welcome [24].
In relation to sociodemographic variables, concentrations of the compound MEOHP were higher
in Irish children who were from an urban background. This compound is a metabolite of DEHP,
and is frequently added to plastics to make them flexible; it is therefore found in many household
products such as table cloths, rainwear and shower curtains. It is difficult to know why concentrations
of this compound should be higher in urban communities; this finding was not evident in children in
the overall DEMOCOPHES results [13]. Urban residence has however been associated with higher
concentrations of MiBP in mothers and children in Germany [15], and also in Egyptian women and
this has been attributed to lifestyle and behavioral factors [25]. In contrast concentrations MiBP and
also MEP were higher in Spanish children from rural areas and this was ascribed to either lifestyle
or environmental factors in their location 14]. Higher concentrations of some phthalate compounds
have also been noted in mothers and children living in rural areas and this has been attributed to an
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increased exposure to PVC in these areas [16]. Both MiBP and MnBP in Chinese children have also
been associated with urban living and this has been attributed to run-off from electrical equipment in
the heavily industrialized area where the study was undertaken [26]. Studies in the Czech Republic,
Hungary and Slovakia have not detected an impact of rural versus urban living on concentrations of
this compound [27]. No difference was also noted between the concentrations of phthalate metabolites
in urban and rural mothers and children in a Danish study [28]. The varying patterns of phthalate
exposure noted with respect to location are indicative of the varying exposure of populations to
phthalate compounds in general and reflect the ubiquitous nature of the product.
The only other sociodemographic variable that was correlated with exposure was educational
attainment, where concentrations of MiBP were lower in both Irish mothers and their children as
educational achievement in the household increased. Similarly, increased educational attainment in the
household was also associated with lower concentrations of the DEHP metabolites, MEOHP, MEHHP
and MEHP in the DEMOCOPHES cohort. Educational attainment has been related to perceived
concern about the dangers of chemicals in the environment as well as being proactive in engaging in
health behaviour to reduce exposure [4,29].
MEP and MiBP were the compounds that showed the highest concentration in both children and
mothers. Exposure to household products such as perfumes, colognes, deodorants, soaps, shampoos
and hand lotions will result in the excretion of MEP. Concentrations of MEP in Irish children were
correlated with use of personal care products. Higher concentrations of MEP have recently been
associated with obesity [11]; and this may have also been a contributing factor as childhood obesity is
a significant issue in Ireland [30]. This association would require further investigation as body mass
index was not calculated in the current study. Surprisingly, concentrations of MEP in Irish mothers
were not associated with the use of personal care products. Irish women use cosmetics, as evidenced
by national beauty and personal care market figures which estimate that the market was valued at €988
million for 2011 and is due to grow by 3% over the year [31]. It is therefore difficult to account for this
finding. In contrast, concentrations of MEP were associated with use of personal care products in both
mothers and children in the DEMOCOPHES cohort, in mothers in Spain who used body lotions and
creams, and in children in Spain who used fragranced products [14] and again in users of personal care
products in the Czech Republic, Hungary and Slovakia [27]. MEP concentrations were also associated
with the use of fragrances and make-up in German mothers [15] and with eye makeup and sunscreen
in Swedish mothers [16]. Although exposure to personal care products was only associated with
concentrations of MEP in Irish children, concentrations of this compound in Irish mothers were linked
with the consumption of convenience foods in the last 24 h. Likewise, the consumption of fast foods
was associated with MiBP in Irish mothers, but not in their children. Such foods are often wrapped
in plastic. Fast food has been identified as a possible source of exposure to DEHP and DiNP in the
U.S. [17] and MBzP was associated with increased consumption of fast food in Spain [14]. Exposure
to PVC was the only factor associated with concentrations of MiBP in Irish children. Similarly, PVC
exposure in children was associated with MBzP and DEHP metabolites in Germany [15], and also
with MnBP and MBzP in Spanish children [14]. PVC is the most common product that contains DiBP,
the precursor for MiBP. In the European DEMOCOPHES study exposure to PVC was associated not
only with MiBP concentrations, but also with MBzP concentrations in mothers and children and
MnBP in mothers [13]. MEHP, MEHHP and MEOHP concentrations, the metabolites of DEHP, were
associated with chewing gum in Irish children. This finding is similar to those of the DEMOCOPHES
cohort which also found an association between chewing gum use and MEHHP and MEOHP [13]. No
such association between chewing gum use and phthalate exposure was found in Irish mothers. An
association between chewing gum and phthalates has been attributed to chewing gum being a proxy
for foods that are processed, flavoured and packaged [13]. DEHP (the precursor of MEHP, MEHHP
and MEOHP) was identified by the EU in February 2017 as an endocrine disrupting chemical which
may damage fertility and the unborn child [32]. MnBP excretion will result from exposure to DBP.
DBP is found in many products including paints, hair spray and nail polish. MnBP concentrations
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in Irish women were associated with the use of plastic gloves and in the DEMOCOPHES study with
exposure to PVC and personal care products. Interestingly, while no association was noted between
DEHP metabolites and the use of PCPs in Irish mothers, their use was inversely related with the use of
PCP products in the DEMOCPHES cohort [13].
The health significance of the findings of this study is unclear. Work has been undertaken on
reference values of specified chemicals by the German Human Biomonitoring Commission, and is
based on the 95% confidence interval of the 95th percentile of the concentration of a chemical substance
in a population. Such reference values cannot be used to assess health risk [33]. The concentrations
of MBzP, MiBP and MnBP in both Irish children and their mothers were below such reference
concentrations established [34]. In relation to the sum of the metabolites 5OH-MEHP and 5oxo-MEHP
the German Human Biomonitoring Commission published two guidance values, HBM –I and HBM II.
HBM I values are those values below which there is no risk for human health. HBM II concentrations
are concentrations above which there is an increased risk for adverse effects. The HBM I value of these
metabolites was 500 µg/L in children and 300 µg/L in adults. No concentrations in the Irish children
were above HBM concentrations II, in contrast to 1.7% of the children in the German study. A smaller
number, 0.02% of mothers exceeded the lower threshold of 300 µg/L for adults in Ireland. However,
studies of the total diet in Ireland have shown that the overall exposure of the Irish population to
phthalates from food is low in both adult and child population groups; average, as well as above
average exposure to phthalates was found to be well below the respective Tolerable Daily Intake set
by the European Food Safety Authority [35]. However, in view of the concerns regarding the links of
phthalates with cancer, reproductive toxicity, asthma and other illnesses, caution would seem to be the
best policy until further information is available. In addition, continuous human biomonitoring will
be necessary to track changes in exposure to pollutants over time [15]. In that regard, the assessment
of phthalate exposure of people who develop cancer and who are entered in the Irish National Cancer
Registry would also be of interest.
The supply and use of certain phthalates are restricted by various pieces of EU legislation.
Regulation 1907/2006 [36] or REACH (Registration, Evaluation, Authorisation and Restriction of
Chemicals) aims to improve the protection of human health and the environment from risks that can
be posed by chemicals while enhancing the competitiveness of the EU chemicals industry. Regulation
10/2011 [37] controls phthalate use in food contact materials, DEHP, BzBP, DBP, DiNP and DiDP are
the only phthalates permitted as plasticisers. DBP, DiBP and BzBP are prohibited in Cosmetics by
Regulation 1223/2009 [38]. Toy safety is controlled by Directive 2009/48/EC [39] which does not
mention phthalates, but toys containing substances of very high concern (SVHC) above 0.1% are not
compliant with REACH.
There are some issues that need to be kept in mind when interpreting this data; phthalates have a
relatively short half-life in the body and the concentrations obtained in this study represent exposure
over the previous 12 h. Exposure to products that may not occur on a daily basis may not result in
high biomarker concentrations. Analysis of the differences in urinary concentrations by demographic
factors and factors associated with exposure was undertaken using univariate analysis (One-way
Anova). Further insight in terms of the relative importance of each predictor would have been achieved
if multivariate techniques such as multiple regression were employed. In addition, the sample is not
representative of the age and sex composition of the Irish population, ideally repeated testing on larger
samples would be needed at regular intervals using larger, representative samples as in NHANES
studies [40] , in order to more fully comprehend the impacts of exposures to phthalate sources on
biological samples. Association of such work with disease registries would also be useful.
5. Conclusions
Exposure to phthalates is extensive and from multiple sources. All seven phthalate compounds
were detected in all of the children’s samples and five of the seven compounds were found in all of the
mother’s samples. The urinary concentrations of the majority of the phthalate metabolites were higher
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in children than in their mothers. Exposure to chewing gum, PVC and PCP in Ireland were associated
with higher concentrations in children, and consumption of fast foods and convenience foods were
a significant factor in mothers. Human Biomonitoring is a useful tool for assessing overall exposure
from multiple diverse sources, however further work is needed in order to more fully understand
the determinants of distribution of these compounds and their impact on health. A copy of the
questionnaire could be found in the supplementary material.
Supplementary Materials: The following are available online at www.mdpi.com/1660-4601/14/12/1456/s1,
DEMOCOPHES Basic Questionnaire.
Acknowledgments: We would like to acknowledge the funders of the DEMOCOPHES project (LIFE09
ENV/BE/000410) which was jointly financed by the European Commission Programme LIFE and each
participating country (http://www.eu-hbm.info/democophes/project-partners). In addition, we would like
to thank the COPHES project for providing the operational and scientific framework (European Community’s
Seventh Framework Programme—DG Research Grant Agreement Number 244237). Special thanks to all the
mothers and children who agreed to participate in the study. In addition the WP team leaders and the national
implementation teams, particularly the Irish national team (Catherine Cosgrove, David O’Brien, Rita O’Grady,
Niamh McGrath, Anita Larini, Carol Nolan, Gemma McGrane and Sarah Duffy) for support in terms of data
collection, analysis, and interpretation. We would like to thank Claire Dunne and Fiona Kavanagh for proof
reading and assistance throughout the project, and Padraig Manning, Clinical Librarian and Elaine Scanlon,
Library assistant from the HSE library in Steevens’ hospital, Dublin 8 for their assistance in accessing the literature.
Author Contributions: In the Irish work, Elizabeth Cullen wrote the paper and provided medical input.
David S. Evans assisted with the writing and performed the statistical analysis. Chris Griffin undertook the
chemical analysis with assistance from Padraig Burke, Rory Mannion and Andrew Flanagan. Toxicological advice
was provided by Michael Ryan, Conway Institute of Biomolecular and Biomedical Research, University College
Dublin 4, and the project was managed by Maurice Mulcahy, Anne Kellegher and Damien Burns. Dominique
Aerts and Pierre Biot coordinated the entire DEMOCOPHES project, and the leaders of the WP teams were
Argelia Castaño, Ludwine Casteleyn, Marike Kolossa-Gehring, Gerta Schwedler, Jürgen Angerer, Louis Bloemen,
Holger M. Koch, Ludwine Casteleyn, Anke Joas, Reinhard Joas, Lisbeth E. Knudsen, Greet Schoeters and Ovnair
Sepai. All the authors read and commented on earlier drafts of the article.
Conflicts of Interest: The authors declare no conflict of interests.
References
1. Schindler, B.K.; Esteban, M.; Koch, H.M.; Castano, A.; Koslitz, S.; Cañas, A.; Casteleyn, L.;
Kolossa-Gehring, M.; Schwedler, G.; Schoeters, G.; et al. The European COPHES/DEMOCOPHES
project: Towards transnational comparability and reliability of human biomonitoring results. Int. J. Hyg.
Environ. Health 2014, 217, 653–661. [CrossRef] [PubMed]
2. Comittee on Toxicity of Chemicals in Food Consumer Products and the Environment. COT Statement on
Dietary Exposure to Phthalates, Data from the Total Diet Study; Food Standards Agency: London, UK, 2011.
3. Bradley, E.L. Determination of Phthalates in Foods and Establishing Methodology to Distinguish Their Source; Food
Standards Agency: London, UK, 2012.
4. Goen, T.; Dobler, L.; Koschorreck, J.; Müller, J.; Wiesmüller, G.A.; Drexler, H.; Kolossa-Gehring, M. Trends
of the internal phthalate exposure of young adults in Germany—Follow-up of a retrospective human
biomonitoring study. Int. J. Hyg. Environ. Health 2011, 215, 36–45. [CrossRef] [PubMed]
5. Meeker, J.D.; Sathyanarayana, S.; Swan, S.H. Phthalates and other additives in plastics: Human exposure
and associated health outcomes. Philos. Trans. R. Soc. B Biol. Sci. 2009, 364, 2097–2113. [CrossRef] [PubMed]
6. Hauser, R.; Calafat, A. Phthalates and human health. Occup. Environ. Med. 2005, 62, 806–818. [CrossRef]
[PubMed]
7. Martino-Andrade, A.J.; Liu, F.; Sathyanarayana, S.; Barrett, E.S.; Redmon, J.B.; Nguyen, R.H.N.; Levine, H.;
Swan, S.H. Timing of prenatal phthalate exposure in relation to genital endpoints in male newborns.
Andrology 2016, 4, 585–593. [CrossRef] [PubMed]
8. Nassan, F.L.; Coull, B.A.; Skakkebaek, N.E.; Williams, M.A.; Dadd, R.; Mínguez-Alarcón, L.; Krawetz, S.A.;
Hait, E.J.; Korzenik, J.R.; Moss, A.C.; et al. A crossover-crossback prospective study of dibutyl-phthalate
exposure from mesalamine medications and semen quality in men with inflammatory bowel disease.
Environ. Int. 2016, 95, 120–130. [CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2017, 14, 1456 11 of 12
9. Den Hond, E.; Tournaye, H.; de Sutter, P.; Ombelet, W.; Baeyens, W.; Covaci, A.; Cox, B.; Nawrot, T.S.; van
Larebeke, N.; D’Hooghe, T. Human exposure to endocrine disrupting chemicals and fertility: A case-control
study in male subfertility patients. Environ. Int. 2015, 84, 154–160. [CrossRef] [PubMed]
10. Robinson, L.; Miller, R. The impact of bisphenol a and phthalates on allergy, asthma, and immune function:
A review of latest findings. Curr. Environ. Health Rep. 2015, 2, 379–387. [CrossRef] [PubMed]
11. Teitelbaum, S.L.; Mervish, N.; Moshier, E.L.; Vangeepuram, N.; Galvez, M.P.; Calafat, A.M.; Silva, M.J.;
Brenner, B.L.; Wolff, M.S. Associations between phthalate metabolite urinary concentrations and body size
measures in New York city children. Environ. Res. 2012, 112, 186–193. [CrossRef] [PubMed]
12. Muscogiuri, G.; Colao, A. Phthalates: New cardiovascular health disruptors? Arch. Toxicol. 2017, 91,
1513–1517.
13. Den Hond, E.; Govarts, E.; Smolders, W.H.; Smolders, R.; Casteleyn, L.; Kolossa-Gehring, M.; Schwedler, G.;
Seiwert, M.; Fiddicke, U.; Castaño, A.; et al. First steps toward harmonized human biomonitoring in Europe:
Demonstration project to perform human biomonitoring on a European scale. Environ. Health Perspect. 2015,
123, 255–263. [CrossRef] [PubMed]
14. Cutanda, F.; Koch, H.M.; Esteban, M.; Sánchez, J.; Angerer, J.; Castaño, A. Urinary concentrations of eight
phthalate metabolites and bisphenol A in mother-child pairs from two Spanish locations. Int. J. Hyg.
Environ. Health 2015, 218, 47–57. [CrossRef] [PubMed]
15. Schwedler, G.; Selwert, M.; Fiddicke, U.; Ißleb, S.; Hölzer, J.; Nendza, J.; Wilhelm, M.; Wittsiepe, J.; Koch, H.M.;
Schindler, B.K.; et al. Human biomonitoring pilot study DEMOCOPHES in Germany: Contribution to a
harmonized European approach. Int. J. Hyg. Environ. Health 2017, 220, 686–696. [CrossRef] [PubMed]
16. Larsson, K.; Ljung Bjorkland, K.; Palm, B.; Wennberg, M.; Kaj, L.; Lindh, C.H.; Jönsson, B.A.G.; Berglund, M.
Exposure determinants of phthalates, parabens, bisphenol A and triclosan in Swedish mothers and their
children. Environ. Int. 2014, 73, 323–333. [CrossRef] [PubMed]
17. Zota, A.R.; Phillips, C.; Mitro, S.D. Recent fast food consumption and bisphenol A and phthalates exposures
among the U.S. population in NHANES, 2003–2010. Environ. Health Perspect. 2016, 124, 1521–1528. [CrossRef]
[PubMed]
18. Kasper-Sonnenberg, M.; Koch, H.M.; Wittsiepe, J.; Brüning, T.; Wilhelm, M. Phthalate metabolites and
bisphenol A in urines from German school-aged children: Results of the Duisburg birth cohort and Bochum
cohort studies. Int. J. Hyg. Environ. Health 2014, 217, 830–838. [CrossRef] [PubMed]
19. Exley, K.; Aerts, D.; Biot, P.; Casteleyn, L.; Kolossa-Gehring, M.; Schwedler, G.; Castaño, A.; Angerer, J.;
Koch, H.M.; Esteban, M.; et al. Pilot study testing a European human biomonitoring framework for
biomarkers of chemical exposure in children and their mothers: Experiences in the UK. Environ. Sci. Pollut.
Res. Int. 2015, 22, 15821–15834. [CrossRef] [PubMed]
20. Hartman, C.; Uhi, M.; Weiss, S.; Scharf, S.; König, J. Human biomonitoring of phthalate exposure in Austrian
children and adults and cumulative risk assessment. Int. J. Hyg. Environ. Health 2015, 218, 489–499.
[CrossRef] [PubMed]
21. Wallner, P.; Kundi, M.; Hohenblum, P.; Scharf, S.; Hutter, H.P. Phthalate metabolites, consumer habits and
health effects. Int. J. Environ. Res. Public Health 2016, 13, 717. [CrossRef] [PubMed]
22. Koch, H.M.; Ruther, M.; Schitze, A.; Conrad, A.; Pälmke, C.; Apel, P.; Brüning, T.; Kolossa-Gehring, M.
Phthalate metabolites in 24-h urine samples of the German Environmental Specimen Bank (ESB) from 1988
to 2015 and a comparison with U.S. NHANES data from 1999 to 2012. Int. J. Hyg. Environ. Health 2017, 220,
130–141. [CrossRef] [PubMed]
23. Den Hond, E.; Paulussen, M.; Geens, T.; Bruckers, L.; Baeyens, W.; David, F.; Dumont, E.; Loots, I.; Morrens, B.;
de Bellevaux, B.N.; et al. Biomarkers of human exposure to personal care products: Results from the Flemish
Environment and Health Study (FLEHS 2007–2011). Sci. Total Environ. 2013, 463, 102–110. [CrossRef]
[PubMed]
24. European Chemicals Agency. Annex to a News Alert ECHA/NA/17/05; European Chemicals Agency: Helsinki,
Finland, 2017.
25. Colacino, J.A.; Soliman, A.S.; Calafat, A.M.; Nahar, M.S.; van Zomeren-Dohm, A.; Hablas, A.; Seifeldin, I.A.;
Rozek, L.S.; Dolinoy, D.C. Exposure to phthalates among premenstrual girls from rural and urban Gharbiah,
Egypt: A pilot exposure assessment study. Environ. Health 2011, 10, 40. [CrossRef] [PubMed]
26. Wu, W.; Zhou, F.; Wang, F.; Ning, Y.; Yang, J.Y.; Zhou, Y.K. Phthalate concentrations and related factors in
children aged 6–12 years. Environ. Pollut. 2017, 220, 990–996. [CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2017, 14, 1456 12 of 12
27. Cerna, M.; Maly, M.; Rudnai, P.; Középesy, S.; Náray, M.; Halzlová, K.; Jajcaj, M.; Grafnetterová, A.;
Krsková, A.; Antošová, D.; et al. Case study: Possible differences in phthalates exposure among the
Czech, Hungarian, and Slovak populations identified based on the DEMOCOPHES pilot study results.
Environ. Res. 2015, 141, 118–124. [CrossRef] [PubMed]
28. Frederiksen, H.; Nielsen, J.K.; Morck, T.A.; Hansen, P.W.; Jensen, J.F.; Nielsen, O.; Andersson, A.-M.;
Knudsen, L.E. Urinary excretion of phthalate metabolites, phenols and parabens in rural and urban Danish
mother-child pairs. Int. J. Hyg. Environ. Health 2013, 216, 772–883. [CrossRef] [PubMed]
29. Valvi, D.; Montura, N.; Ventura, R.; Casas, M.; Casas, L.; Sunyer, J.; Vrijheid, M. Variability and predictors of
urinary phthalate metabolites in Spanish pregnant women. Int. J. Hyg. Environ. Health 2015, 218, 220–231.
[CrossRef] [PubMed]
30. Heinen, M.; Murrin, C.; Daly, L.; O’Brien, J.; Heavey, P.; Kilroe, J.; O’Brien, M.; Scully, H.; Mulhern, L.M.;
Lynam, A.; et al. The Childhood Obesity Surveillance Initiative (COSI) in the Republic of Ireland: Findings from
2008, 2010 and 2012; Health Service Executive: Dublin, Ireland, 2014.
31. Mintel. Beauty and Personal Care—Ireland. Consumer Market Research Report August 2011. Available
online: http://store.mintel.com/beauty-and-personal-care-ireland-august-2011 (accessed on 3 March 2017).
32. Health and Environment Alliance. Europe Finally Recognises Four Phthalates as Human Endocrine
Disruptors. 2017. Available online: http://www.env-health.org/resources/press-releases/article/europe-
finally-recognises-four (accessed on 6 April 2017).
33. Apel, P.; Angerer, J.; Wilhelm, M.; Kolossa-Gehring, M. New HBM values for emerging substances, inventory
of reference and HBM values in force, and working principles of the German Human Biomonitoring
Commission. Int. J. Hyg. Environ. Health 2017, 220, 152–166. [CrossRef] [PubMed]
34. Schulz, C.; Wilhelm, M.; Heudorf, U.; Kolossa-Gehring, M. Update of the reference and HBM values derived
by the German Human Biomonitoring Commission. Int. J. Hyg. Environ. Health 2011, 215, 26–35. [CrossRef]
[PubMed]
35. Food Safety Authority of Ireland. Report on a Total Diet Study Carried Out by the Food Safety Authority of Ireland
in the Period 2012–2014; Food Safety Authority of Ireland: Dublin, Ireland, 2016.
36. European Union. Regulation (EC) No 1907/2006 of the European parliament and of the Council of 18
December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals
(REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing
Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council
Directive 76/769/EECC and Commission Directives 91/155/EEC, 93/67/EEC. 93/105/EC and 2000/21/EC.
Off. J. Eur. Union 2006, L396, 1–849.
37. European Union. Commission Regulation (EU) No 10/2011 of 14 January 2011 on plastic materials and
articles intended to come into contact with food. Off. J. Eur. Union 2011, L12, 1–89.
38. European Union. Regulation (EC) No 1223/2009 of the European Parliamentand of the Council of 30
November 2009 on Cosmetic Products. Off. J. Eur. Union 2009, L342, 59–209.
39. European Commission Enterprise and industry Directorate-General. Toy Safety Directive 2009/48/EC,
An Explanatory Guidance Document; European Commission: Brussels, Belgium, 2013.
40. Department of Health and Human Services and Centers for Disease Control and Prevention. Fourth National
Report on Human Exposure to Environmental Chemicals; Department of Health and Human Services and Centers
for Disease Control and Prevention: Atlanta, GA, USA, 2009.
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
